A virtual meeting is scheduled for June 13, with Piper Sandler as the host, featuring CMPX. This event will provide insights into the company's strategies and performance, offering investors an opportunity to engage with CMPX leadership. The meeting aims to shed light on CMPX's market positioning and future prospects.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 9 analysts, the average target price for Compass Therapeutics Inc (CMPX, Financial) is $13.22 with a high estimate of $32.00 and a low estimate of $6.00. The average target implies an upside of 415.85% from the current price of $2.56. More detailed estimate data can be found on the Compass Therapeutics Inc (CMPX) Forecast page.
Based on the consensus recommendation from 9 brokerage firms, Compass Therapeutics Inc's (CMPX, Financial) average brokerage recommendation is currently 1.3, indicating "Buy" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.